Literature DB >> 2185088

Mutation in cytochrome P-450-dependent 14 alpha-demethylase results in decreased affinity for azole antifungals.

H Vanden Bossche1, P Marichal, J Gorrens, D Bellens, H Moereels, P A Janssen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2185088     DOI： 10.1042/bst0180056

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN： 0300-5127            Impact factor:   5.407


× No keyword cloud information.
  32 in total

Review 1.  Sterol 14alpha-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms.

Authors:  Galina I Lepesheva; Michael R Waterman
Journal:  Biochim Biophys Acta       Date:  2006-08-02

2.  Fluconazole treatment is effective against a Candida albicans erg3/erg3 mutant in vivo despite in vitro resistance.

Authors:  Taiga Miyazaki; Yoshitsugu Miyazaki; Koichi Izumikawa; Hiroshi Kakeya; Shunichi Miyakoshi; John E Bennett; Shigeru Kohno
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

Review 3.  Antifungal agents: chemotherapeutic targets and immunologic strategies.

Authors:  N H Georgopapadakou; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

4.  Molecular biological characterization of an azole-resistant Candida glabrata isolate.

Authors:  P Marichal; H Vanden Bossche; F C Odds; G Nobels; D W Warnock; V Timmerman; C Van Broeckhoven; S Fay; P Mose-Larsen
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

5.  Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients.

Authors:  J L Lopez-Ribot; R K McAtee; S Perea; W R Kirkpatrick; M G Rinaldi; T F Patterson
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

6.  In vitro activity of a new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.

Authors:  F Barchiesi; A L Colombo; D A McGough; A W Fothergill; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

7.  In vitro and in vivo effects of 14alpha-demethylase (ERG11) depletion in Candida glabrata.

Authors:  H Nakayama; N Nakayama; M Arisawa; Y Aoki
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

8.  Distinct patterns of gene expression associated with development of fluconazole resistance in serial candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.

Authors:  J L Lopez-Ribot; R K McAtee; L N Lee; W R Kirkpatrick; T C White; D Sanglard; T F Patterson
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

9.  Functional genomic analysis of fluconazole susceptibility in the pathogenic yeast Candida glabrata: roles of calcium signaling and mitochondria.

Authors:  Rupinder Kaur; Irene Castaño; Brendan P Cormack
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

10.  Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance.

Authors:  F S Clark; T Parkinson; C A Hitchcock; N A Gow
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.